Home › Funds › Intellectus Partners, LLC › ABCL
Intellectus Partners, LLC position in ABCL
ABCELLERA BIOLOGICS INC · Health Care
Intellectus Partners, LLC reported holding 584,133 shares of ABCL (ABCELLERA BIOLOGICS INC) in its Q3 2026 13F filing — a position valued at US$8.5M, representing 1.42% of its reported portfolio and ranking #13 among its reported holdings. Intellectus Partners, LLC has disclosed ABCL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Intellectus Partners, LLC's ABCL position evolved
Intellectus Partners, LLC first disclosed a stake in ABCL in Q3 2023 at 876,633 shares (US$4.0M). The position peaked in Q3 2026 at 584,133 shares, worth US$8.5M. Across 13 filings, Intellectus Partners, LLC increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 584,133 shares valued at US$8.5M — an increase of 32,550 shares quarter over quarter.. Notable position changes include a 39% trim in Q1 2024 (shares fell 35% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 876.63K | $4.03M | New |
| Q4 2023 | 887.28K | $5.07M | Add |
| Q1 2024 | 541.78K | $2.45M | Reduce |
| Q2 2024 | 545.53K | $1.61M | Add |
| Q3 2024 | 545.53K | $1.42M | Hold |
| Q4 2024 | 547.53K | $1.60M | Hold |
| Q1 2025 | 548.13K | $1.22M | Hold |
| Q2 2025 | 548.13K | $1.88M | Hold |
| Q3 2025 | 543.13K | $2.73M | Reduce |
| Q4 2025 | 523.38K | $1.79M | Reduce |
| Q1 2026 | 546.08K | $1.91M | Add |
| Q2 2026 | 551.58K | $4.33M | Add |
| Q3 2026 | 584.13K | $8.52M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABCL and 13F data
ABCL (ABCELLERA BIOLOGICS INC) is a Health Care company. 41 other funds we track also report a position in ABCL — the largest reported positions include BAKER BROS. ADVISORS LP (US$259.1M), ArrowMark Colorado Holdings LLC (US$32.2M), Guardian Partners Inc. (US$8.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABCL
- BAKER BROS. ADVISORS LP 33.01M sh · $259.15M · Q2 2026
- ArrowMark Colorado Holdings LLC 4.11M sh · $32.22M · Q2 2026
- Guardian Partners Inc. 596.00K sh · $8.70M · Q3 2026
- SOFTBANK GROUP CORP. 345.16K sh · $2.71M · Q2 2026
More on Intellectus Partners, LLC
FAQ
How long has Intellectus Partners, LLC held ABCL?
Intellectus Partners, LLC has disclosed ABCL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Intellectus Partners, LLC's current position in ABCL?
As of Q3 2026, Intellectus Partners, LLC holds 584.13K shares of ABCL (ABCELLERA BIOLOGICS INC), valued at $8.52M, representing 1.42% of its reported portfolio and ranking #13.
Has Intellectus Partners, LLC been buying or selling ABCL?
In the latest 13F filing (Q3 2026), Intellectus Partners, LLC increased its position in ABCL. The position peaked in Q3 2026 at 584.13K shares.
Which other funds hold ABCL?
Other major institutional holders of ABCL include BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, Guardian Partners Inc., among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.